Centauri Therapeutics' Unattributed Round

Centauri Therapeutics raised a round of funding on January 19, 2016. Investors include Animatrix Capital.

Centauri Therapeutics is a biotechnology company focused on the discovery and development of novel molecules targeting life-threatening diseases, such as infectious diseases and cancer.…

Articles about Centauri Therapeutics' Unattributed Round: